Trazium

Trazium (EGYT-3,615) is an antidepressant drug which was never marketed.[1] It has psychostimulant-like effects and its actions appear to be mediated by the dopaminergic and adrenergic systems.[2] It was formulated as a salt with ethanesulfonic acid and given the generic name trazium esilate (INN).[3]

Trazium
INN: Trazium esilate
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
IUPAC name
  • 1-(4-Chlorophenyl)-1-hydroxy-1,4-dihydro[1,2,4]triazino[6,1-a]isoquinolin-5-ium
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H13ClN3O
Molar mass310.76 g·mol−1

References

  1. David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
  2. Gyertyán I, Petöcz L, Bajnógel J, et al. (July 1989). "Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate". Arzneimittel-Forschung. 39 (7): 775–81. PMID 2551306.
  3. "Trazium Esilate". ChemSpider.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.